| Title | Author(s) | Year | View Count |
 | Regulators of mammalian Hippo pathway in cancer | Liu, AM; Wong, KF; Jiang, X; Qiao, Y; Luk, JM | 2012 | 57 |
| Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study | Liu, AM; Yao, TJ; Wang, W; Wong, KF; Lee, NP; Fan, ST; Poon, RTP; Gao, C; Luk, JM | 2012 | 98 |
| Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma | Sung, WK; Zheng, H; Li, S; Chen, R; Liu, X; Li, Y; Lee, NP; Lee, WH; Ariyaratne, PN; Tennakoon, C; Mulawadi, FH; Wong, KF; Liu, AM; Poon, RT; Fan, ST; Chan, KL; Gong, Z; Hu, Y; Lin, Z; Wang, G; Zhang, Q; Barber, TD; Chou, WC; Aggarwal, A; Hao, K; Zhou, W; Zhang, C; Hardwick, J; Buser, C; Xu, J; Kan, Z; Dai, H; Mao, M; Reinhard, C; Wang, J; Luk, JM | 2012 | 134 |
| An update on targeting Hippo-YAP signaling in liver cancer | Liu, AM; Xu, Z; Luk, JM | 2012 | 71 |
| Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122 | Boutz, DR; Collins, PJ; Suresh, U; Lu, M; Ramírez, CM; FernándezHernando, C; Huang, Y; Abreu, RDS; Le, SY; Shapiro, BA; Liu, AM; Luk, JM; Aldred, SF; Trinklein, ND; Marcotte, EM; Penalva, LOF | 2011 | 162 |
 | Proteomics of hepatocellular carcinoma in chinese patients | Luk, JM; Liu, AM | 2011 | 118 |
| Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma | Ivanovska, I; Zhang, C; Liu, AM; Wong, KF; Lee, NP; Lewis, P; Philippar, U; Bansal, D; Buser, C; Scott, M; Mao, M; Poon, RTP; Fan, ST; Cleary, MA; Luk, JM; Dai, H | 2011 | 99 |
| AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma | Xu, MZ; Chan, SW; Liu, AM; Wong, KF; Fan, ST; Chen, J; Poon, RT; Zender, L; Lowe, SW; Hong, W; Luk, JM | 2011 | 430 |
| Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma | Liu, AM; Zhang, C; Burchard, J; Fan, ST; Wong, KF; Dai, H; Poon, RT; Luk, JM | 2011 | 71 |
| DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival | Luk, JM; Burchard, J; Zhang, C; Liu, AM; Wong, KF; Shek, FH; Lee, NP; Fan, ST; Poon, RT; Ivanovska, I; Philippar, U; Cleary, MA; Buser, CA; Shaw, PM; Lee, CN; Tenen, DG; Dai, H; Mao, M | 2011 | 56 |
| Targeting YAP and Hippo signaling pathway in liver cancer | Liu, AM; Xu, MZ; Chen, J; Poon, RT; Luk, JM | 2010 | 462 |
| MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties | Liu, AM; Poon, RTP; Luk, JM | 2010 | 210 |
| MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma | Burchard, J; Zhang, C; Liu, AM; Poon, RTP; Lee, NPY; Wong, KF; Sham, PC; Lam, BY; Ferguson, MD; Tokiwa, G; Smith, R; Leeson, B; Beard, R; Lamb, JR; Lim, L; Mao, M; Dai, H; Luk, JM | 2010 | 480 |
|
